Malignant Hyperthermia is a severe reaction to specific anesthetic agents, such as volatile anesthetics and succinylcholine. It is characterized by rapid onset of hypermetabolism in skeletal muscles, leading to symptoms such as muscle rigidity, hyperthermia, acidosis, and rhabdomyolysis. Children with a family history of MH or unexplained complications during anesthesia are often candidates for CHCT.